Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Application of therapeutically feasible doses of EGb ® 761 for 48 h caused endothelial nitric oxide ( NO ) production by increasing endothelial nitric oxide synthase (eNOS) promoter activity and eNOS expression in vitro.”
Cellular and Molecular Life Sciences • 2007 | View Paper
“Moreover, EGb 761 markedly increased SOD activity, reduced MDA levels and MPO activity, and suppressed NO generation accompanied by down-regulation of iNOS expression (P < 0.05 or 0.01).”